2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI

Details for Australian Patent Application No. 2004303461 (hide)

Owner H. Lundbeck A/S

Inventors Kehler, Jan; Juhl, Karsten; Norgaard, Morten Bang; Sejberg, Jimmy

Agent Watermark

Pub. Number AU-B-2004303461

PCT Pub. Number WO2005/061455

Priority PA 200301923 23.12.03 DK

Filing date 21 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 28 April 2011

International Classifications

C07D 209/30 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/061455 Priority application(s): WO2005/061455

17 August 2006 Amendment Made

  The nature of the amendment is: Delete priority details 60/532,593 23 Dec 2003 US 2004303741 AstraZeneca AB The nature of the amendment is: Amend the invention title to read Diphenylazetidinone derivatives processing cholesterol absorption inhibitory activity

28 April 2011 Application Accepted

  Published as AU-B-2004303461

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303464-Oligomeric compounds for the modulation of BLC-2

2004303454-Plastic collapsible bottle with accordionlike arranged bellows ridges